Ensuring adherence for a new therapy
A pharmaceutical company was launching a new peanut allergy medication and wanted to better understand how to encourage engagement and adherence.
Exploring needs and emotions
The Connell Group conducted qualitative and quantitative research among parents of children with peanut allergies to better understand:
- The emotional toll placed on caregivers
- The beliefs and barriers that could limit adoption
- The functional and emotional benefits that they seek
Initiating an effective product launch
Based on insights, Connell Group helped the client to develop a differentiated value proposition for their therapy, along with a go-to-market strategy to drive engagement and adoption by concerned parents.